-
Loading metrics
A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives
- Chunhua Zhang,
- Hua Liang,
- Yanni Qin,
- Xiaolan Tan,
- Xiaoqing Su,
- Xin Tian,
- Yumei Nong
x
- Published: January 22, 2026
- https://doi.org/10.1371/journal.pone.0341154